
An oral, Smac mimetic that also serves as an inhibitor of apoptosis proteins: XIAP, cIAP1, and cIAP2. AT-406 has been shown to inhibit the survival of cancer cells and is currently in phase 1 clinical trials for human cancer treatment.
Shipping: Available products typically ship within 24/48h, via priority shipping.
Do you need support? Contact Customer Service or Technical Support.
Online Account
Access or Create Your Account
Regulatory Status |
RUO – Research Use Only |
---|